EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Vector-free intra-airway in vivo epigenetic editing

Naohiro Yano, Mohankumar Ramar, David J Gregory, Alexey V Fedulov

Trends in Biotechnology · 2025

DOI: 10.1016/j.tibtech.2025.05.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Biotechnology, 2025. Verfasst von Naohiro Yano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of Brown University, Division of Surgical Research, Department of Surgery, Rhode Island Hospital, NAB B001. 593 Eddy Street, Providenc…. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Gene Editing. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIEHS NIH HHS, NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted, promoter-specific removal of DNA methylation marks is emerging as a promising strategy for experimental and therapeutic regulation of gene expression. Research to date has relied largely on the expression of transgene-encoded epigenetic editor constructs in target cells. While effective for in vitro demonstrations, alternative approaches are needed for greater translatability to humans. Here, we describe the design of recombinant, gene-targeted epigenetic editor proteins that are directly taken up by mouse lung cells following administration in vivo without transgenesis, vectors, or packaging tools. Proteins are targeted to their intended promoter using either dCas9 or artificial zinc finger domains, and thymine-DNA-glycosylase (TDG) and ten-eleven translocation proteins (Tet) catalytic domains mediate specific demethylation. Results demonstrate intranuclear arrival of epigenetic editors in vitro and in mice, local DNA demethylation, and resulting highly gene-specific derepression of the transcriptional response, which confers sensitivity to interferon (IFN) stimulation. Therefore, this study provides proof of principle for vector-free, targeted promoter demethylation in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticGene EditingAnimalsMicePromoter Regions, GeneticDNA MethylationHumansLungEpigenome Editing

Stichwörter der Autor:innen

Cxcl11aerosoldemethylationepigenetic editingfusion demethylaseintra-airwaypulmonaryvector-free

Autor:innen und Institutionen

  • Medical School of Brown University, Division of Surgical Research, Department of Surgery, Rhode Island Hospital, NAB B001. 593 Eddy Street, Providence, RI 02903, USA.
  • Medical School of Brown University, Division of Surgical Research, Department of Surgery, Rhode Island Hospital, NAB B001. 593 Eddy Street, Providence, RI 02903, USA. Electronic address: alexey@brown.edu.

Förderung

  • NIEHS NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • National Institute of General Medical Sciences
  • Department of Surgery
  • Rhode Island Hospital

Zitieren

APA

Yano, N., Ramar, M., Gregory, D. J., & Fedulov, A. V. (2025). Vector-free intra-airway in vivo epigenetic editing. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2025.05.007

Vancouver

Yano N, Ramar M, Gregory DJ, Fedulov AV. Vector-free intra-airway in vivo epigenetic editing. Trends in Biotechnology. 2025. doi:10.1016/j.tibtech.2025.05.007

BibTeX
@article{Yano2025,
  author = {Yano, Naohiro and Ramar, Mohankumar and Gregory, David J and Fedulov, Alexey V},
  title = {Vector-free intra-airway in vivo epigenetic editing},
  journal = {Trends in Biotechnology},
  year = {2025},
  doi = {10.1016/j.tibtech.2025.05.007}
}
Kostenlos starten →